Search Publications

Filter Publications

2018

2018 Publications

Sapienza MRosaria, Abate F, Melle F, Orecchioni S, Fuligni F, Etebari M, Tabanelli V, Laginestra MAntonella, Pileri A, Motta G, Rossi M, Agostinelli C, Sabattini E, Pimpinelli N, Truni M, Falini B, Cerroni L, Talarico G, Piccioni R, Amente S, Indio V, Tarantino G, Brundu F, Paulli M, Berti E, Facchetti F, Dellino GIvan, Bertolini F, Tripodo C, Rabadan R, Pileri SA.  2018.  Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.. Haematologica. ▶ Go to Pubmed
Lee J-K, Liu Z, Sa JK, Shin S, Wang J, Bordyuh M, Cho HJin, Elliott O, Chu T, Choi SWon, Rosenbloom DIS, Lee I-H, Shin YJae, Kang HJu, Kim D, Kim SYoung, Sim M-H, Kim J, Lee T, Seo YJee, Shin H, Lee M, Kim SHeon, Kwon Y-J, Oh J-W, Song M, Kim M, Kong D-S, Choi JWon, Seol HJun, Lee J-I, Kim STae, Park JOh, Kim K-M, Song S-Y, Lee J-W, Kim H-C, Lee JEon, Choi MGew, Seo SWook, Shim YMog, Zo JIll, Jeong BChang, Yoon Y, Ryu GHa, Kim NKD, Bae JSeol, Park W-Y, Lee J, Verhaak RGW, Iavarone A, Lee J, Rabadan R, Nam D-H.  2018.  Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.. Nat Genet. 50(10):1399-1411.▶ Go to Pubmed
Alvarez MJ, Subramaniam PS, Tang LH, Grunn A, Aburi M, Rieckhof G, Komissarova EV, Hagan EA, Bodei L, Clemons PA, Cruz FSDela, Dhall D, Diolaiti D, Fraker DA, Ghavami A, Kaemmerer D, Karan C, Kidd M, Kim KM, Kim HC, Kunju LP, Langel Ü, Li Z, Lee J, Li H, LiVolsi V, Pfragner R, Rainey AR, Realubit RB, Remotti H, Regberg J, Roses R, Rustgi A, Sepulveda AR, Serra S, Shi C, Yuan X, Barberis M, Bergamaschi R, Chinnaiyan AM, Detre T, Ezzat S, Frilling A, Hommann M, Jaeger D, Kim MK, Knudsen BS, Kung AL, Leahy E, Metz DC, Milsom JW, Park YS, Reidy-Lagunes D, Schreiber S, Washington K, Wiedenmann B, Modlin I, Califano A.  2018.  A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.. Nat Genet. ▶ Go to Pubmed
Rajbhandari P, Lopez G, Capdevila C, Salvatori B, Yu J, Rodriguez-Barrueco R, Martinez D, Yarmarkovich M, Weichert-Leahey N, Abraham BJ, Alvarez MJ, Iyer A, Harenza JLynne, Oldridge D, De Preter K, Koster J, Asgharzadeh S, Seeger RC, Wei JS, Khan J, Vandesompele J, Mestdagh P, Versteeg R, A Look T, Young RA, Iavarone A, Lasorella A, Silva JM, Maris JM, Califano A.  2018.  Cross-cohort analysis identifies a TEAD4 ↔ MYCN positive-feedback loop as the core regulatory element of high-risk neuroblastoma.. Cancer Discov. ▶ Go to Pubmed
Bao X, Guo X, Yin M, Tariq M, Lai Y, Kanwal S, Zhou J, Li N, Lv Y, Pulido-Quetglas C, Wang X, Ji L, Khan MJ, Zhu X, Luo Z, Shao C, Lim D-H, Liu X, Li N, Wang W, He M, Liu Y-L, Ward C, Wang T, Zhang G, Wang D, Yang J, Chen Y, Zhang C, Jauch R, Yang Y-G, Wang Y, Qin B, Anko M-L, Hutchins AP, Sun H, Wang H, Fu X-D, Zhang B, Esteban MA.  2018.  Capturing the interactome of newly transcribed RNA.. Nat Methods. 15(3):213-220.▶ Go to Pubmed
Hui KY, Fernandez-Hernandez H, Hu J, Schaffner A, Pankratz N, Hsu N-Y, Chuang L-S, Carmi S, Villaverde N, Li X, Rivas M, Levine AP, Bao X, Labrias PR, Haritunians T, Ruane D, Gettler K, Chen E, Li D, Schiff ER, Pontikos N, Barzilai N, Brant SR, Bressman S, Cheifetz AS, Clark LN, Daly MJ, Desnick RJ, Duerr RH, Katz S, Lencz T, Myers RH, Ostrer H, Ozelius L, Payami H, Peter Y, Rioux JD, Segal AW, Scott WK, Silverberg MS, Vance JM, Ubarretxena-Belandia I, Foroud T, Atzmon G, Pe'er I, Ioannou Y, McGovern DPB, Yue Z, Schadt EE, Cho JH, Peter I.  2018.  Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease.. Sci Transl Med. 10(423)▶ Go to Pubmed